DelveInsight launched a new report on Idiopathic Pulmonary Fibrosis Market Insights, Epidemiology and Market Forecast 2030.
DelveInsight’s ‘Idiopathic Pulmonary Fibrosis (IPF) – Market Insights, Epidemiology and Market Forecast-2030 report delivers an in-depth understanding of the disease, historical & forecasted epidemiology as well as the market trends of IPFs in the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom) and Japan.
Idiopathic Pulmonary Fibrosis (IPF) is a rare, chronic, progressive fibrosing interstitial pneumonia which is found to affect the middle-aged and older adults; and affects lung tissue (alveoli in particular) by either thickening, stiffening, or persistent and progressive scarring (fibrosis) which increases irreversibly over time. If an individual has IPF, scarring affects the air sacs, limiting the amount of oxygen that gets into the blood. With less oxygen in the blood, one can get breathlessness from everyday activities, like walking. This group of lung disorders is also known as ‘Diffuse Parenchymal Lung Diseases,’ which is characterized by a broader umbrella of ‘Interstitial Lung Diseases (IDLs).
“According to DelveInsight, the total Idiopathic Pulmonary Fibrosis (IPF) prevalent cases in 7 MM was found to be 229,170, in the year 2017.”
Request for a detailed sample copy of the report: https://www.delveinsight.com/sample-request/idiopathic-pulmonary-fibrosis-market
Idiopathic Pulmonary Fibrosis Emerging Therapies:
1. Esbriet (Pirfenidone)
2. Ofev (Nintedanib)
Table of contents
1 Key Insights 2 Executive Summary of Idiopathic Pulmonary Fibrosis 3 Idiopathic Pulmonary Fibrosis Market Overview at a Glance 4 Disease Background and Overview: Idiopathic Pulmonary Fibrosis 5 Case Reports 6 Idiopathic Pulmonary Fibrosis Epidemiology and Patient Population 7 United States Epidemiology 8 EU5 Epidemiology 9 Japan Epidemiology 10 Current Idiopathic Pulmonary Fibrosis Treatment and Medical Practices 11 Unmet needs 12 Idiopathic Pulmonary Fibrosis Marketed Drugs 13 Idiopathic Pulmonary Fibrosis Emerging Drugs 14 Idiopathic Pulmonary Fibrosis 7MM Market Analysis 15 United States 16 EU-5 countries: Market Outlook 17 Japan Market Outlook 18 Idiopathic Pulmonary Fibrosis Market Drivers 19 Idiopathic Pulmonary Fibrosis Market Barriers 20 SWOT Analysis 21 Reimbursement and market access 22 Appendix 23 DelveInsight Capabilities 24 Disclaimer 25 About DelveInsight
Download report: https://www.delveinsight.com/report-store/idiopathic-pulmonary-fibrosis-market
About DelveInsight DelveInsight is a leading Business Consultant, and Market Research Firm focused exclusively on life sciences. It supports pharma companies by providing end to end comprehensive solutions to improve their performance.
Media ContactCompany Name: DelveInsight Business Research LLPContact Person: Kritika RehaniEmail: Send EmailPhone: 9193216187Address:304 S. Jones Blvd #2432 City: Las VegasState: NevadaCountry: United StatesWebsite: https://www.delveinsight.com/